VRTX: Vertex Pharmaceuticals Incorporated Stock

by  •  • Comments Off on VRTX: Vertex Pharmaceuticals Incorporated Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 108,085.94
Enterprise Value ($M) 101,884.74
Book Value ($M) 16,496.30
Book Value / Share 64.24
Price / Book 6.55
NCAV ($M) 3,624.60
NCAV / Share 14.11
Price / NCAV 29.82

Profitability (mra)
Return on Invested Capital (ROIC) -0.05
Return on Assets (ROA) -0.04
Return on Equity (ROE) -0.05

Liquidity (mrq)
Quick Ratio 2.29
Current Ratio 2.65

Balance Sheet (mrq) ($M)
Current Assets 10,008.80
Assets 22,880.50
Liabilities 6,384.20
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 11,020.10
Operating Income 4,603.80
Net Income -535.60
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -492.60
Cash from Investing -3,770.00
Cash from Financing -1,494.90

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
2 days ago 13G Capital Research Global Investors 5.70
02-13 13G/A Capital World Investors 11.20 10.95
02-12 13G/A Fmr Llc 3.60 -28.97

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-14 336,104 1,755,264 19.15
2025-05-13 507,517 2,207,555 22.99
2025-05-12 361,613 1,609,836 22.46
2025-05-09 353,511 1,359,524 26.00

(click for more detail)

Similar Companies
VIGL – Vigil Neuroscience, Inc. VIR – Vir Biotechnology, Inc.
VOR – Vor Biopharma Inc. VTRS – Viatris Inc.
VTYX – Ventyx Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io